Skip to content

Clinical trials

Congenital Hyperinsulinism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Hyperinsulinism Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20093
20132
20152
20163
20171
20181
20193
20202
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting3
No longer available2
Recruiting2
Available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Philadelphia3
Diva De Leon3
Zealand Pharma3
Rezolute2
University of Minnesota2
Xeris Pharmaceuticals2
Baylor College of Medicine1
Cook Children's Health Care System1
Hanmi Pharmaceutical Company Limited1
Miguel Pampaloni1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Hyperinsulinism24
Hyperinsulinism10
Hypoglycemia10
Glucose Metabolism Disorders3
Metabolic Diseases3
Pancreatic Diseases3
Digestive System Diseases2
Insulinoma2
Anemia, Sickle Cell1
Angelman Syndrome1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.